This is important, because almost 30% of patients with a germline PTEN mutation can be identified using the NCCN criteria for PHTS, but only one-third of patients with PHTS fulfill these criteria [72]. The gene discussed is PTEN; the disease is PTEN hamartoma tumor syndrome.